obesity drug news today glp-1 october 27 2025 How do weight-loss drugs work? Market pressure seen as fueling

Roughly 20 million of those people have moderate-to-severe forms of the disease, but 85% of cases go undiagnosed, the company told CNBC earlier this year

The timing of supply-related discontinuations further illustrates how external factors, like national shortages or surges in demand, can abruptly disrupt continuity of care ( 13 15 )

Participants could not tell if they had the sham or real procedure because there are not a lot of symptoms after the procedure, he said

Although widespread adoption of GLP-1 and GLP-1/GIP medications has the potential to improve population health by reducing obesity-related diseases, the financial implications are considerable